Clinical Trials Logo

Filter by:
NCT ID: NCT01924715 Completed - Depression Clinical Trials

Evaluating the Cost Effectiveness of ISTDP: A Quasi Experimental Study

CEISTDP
Start date: January 2008
Phase: N/A
Study type: Observational

Objective: To evaluate whether or not cases treated with Intensive Short-term Dynamic Psychotherapy (ISTDP) facilitate healthcare cost reduction, whether any observed reduction is greater than that of a control group and whether any such gains would be maintained in follow up. Design: A quasi-experimental design was employed in which pre and post healthcare cost and usage data were extracted for all ISTDP treated cases from 1999 to 2008 and compared to parallel measures of a control group of cases referred but never treated.

NCT ID: NCT01924663 Completed - Heart Failure Clinical Trials

Viral Illness in Pediatric Critical Care: Incidence Timing & Severity of Associated Heart Dysfunction & Acute Kidney Injury

MyDAKI-01
Start date: September 2013
Phase:
Study type: Observational

The purpose of this study is to be able to better describe the incidence, timing and severity of myocardial dysfunction and acute kidney injury (AKI) following a documented respiratory viral illness (RSV, adenovirus, metapneumovirus, parainfluenza, influenza, etc.) in pediatric patients.

NCT ID: NCT01924455 Completed - Hepatitis B Clinical Trials

HBV-HIV Coinfection Research Network

Start date: April 2014
Phase:
Study type: Observational

Despite effective ART that can suppress both HIV and HBV, HBV-related liver disease remains a significant co-morbidity in this population. Little is known about the histologic spectrum of liver disease, the significance of complete vs. incomplete HBV suppression, the utility of novel virologic and serum markers of disease severity, and the long-term renal and bone effects of TDF-based therapy. This proposal will address these important questions and impact the science and health of those coinfected with HBV-HIV.

NCT ID: NCT01924026 Completed - Phenylketonuria Clinical Trials

Neurocognitive Outcomes in Mild Hyperphenylalaninemia (MHP)MHP Study

Start date: September 2013
Phase: N/A
Study type: Observational

Phenylketonuria (PKU) is a genetic disorder known to cause severe reduction in intelligence and deficits in cognitive function; it is associated with an elevated level of Phenylalanine (Phe) in blood. Newborn screening and early treatment with restricted protein diet supplemented by a formula of amino-acids will preserve intelligence. In those with the severe form treated from birth, some deficits that affect higher functions of the brain are seen. Given this, there is disagreement about how milder forms of this disease should be managed and what level of Phe is safe to be left untreated. We seek to assess whether higher Phe levels, between 360 and 600µmol/L, are safe with respect to preservation of intelligence and higher cognitive functions.

NCT ID: NCT01923558 Completed - Healthy Clinical Trials

Bioavailability Study of Donepezil Hydrochloride Tablets 23 mg Under Fasting Condition

Start date: October 2010
Phase: Phase 1
Study type: Interventional

To evaluate and compare the relative bioavailability and therefore the bioequivalence of two different formulations of donepezil after a single oral dose administration under fasting conditions.

NCT ID: NCT01923324 Completed - Chronic Pain Clinical Trials

Standard Telephone Consultation for Pain

STC
Start date: July 2005
Phase: N/A
Study type: Interventional

The purpose of this study is to investigate whether pain control for patients with chronic pain is improved by the availability of structured telephone consultations between the patients' family physicians and pain physicians, compared to pain control for patients receiving usual care.

NCT ID: NCT01923259 Completed - Healthy Clinical Trials

Bioavailability Study of Donepezil Hydrochloride Tablets 23 mg Under Fed Condition

Start date: October 2010
Phase: Phase 1
Study type: Interventional

To evaluate and compare the relative bioavailability and therefore the bioequivalence of two different formulations of donepezil after a single oral dose administration under fed conditions.

NCT ID: NCT01923181 Completed - Clinical trials for Diabetes Mellitus, Type 2

Multiple Dose Trial Examining Dose Range, Escalation and Efficacy of Oral Semaglutide in Subjects With Type 2 Diabetes

Start date: December 2, 2013
Phase: Phase 2
Study type: Interventional

This trial is conducted globally. The aim of the trial is to examine the dose range, escalation and efficacy of oral semaglutide in subjects with type 2 diabetes.

NCT ID: NCT01923168 Completed - Breast Cancer Clinical Trials

Study of Letrozole With or Without BYL719 or Buparlisib, for the Neoadjuvant Treatment of Postmenopausal Women

Start date: March 11, 2014
Phase: Phase 2
Study type: Interventional

The purpose of the study was to determine whether treatment with a PI3K inhibitor plus letrozole led to an increase in pathologic clinical response and Objective Response Rate compared to treatment with placebo plus letrozole in patients with Breast cancer.

NCT ID: NCT01922258 Completed - Alzheimer's Disease Clinical Trials

Safety and Tolerability Study of Flexible Dosing of Brexpiprazole in the Treatment of Subjects With Agitation Associated With Dementia of the Alzheimer's Type

Start date: September 2013
Phase: Phase 3
Study type: Interventional

To compare the efficacy of flexible dosing of brexpiprazole with placebo in subjects with agitation associated with dementia of the Alzheimer's type